{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T23:53:13Z","timestamp":1792885993144,"version":"4.5.0"},"reference-count":153,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>The role of interleukin-18 (IL-18) and inflammasomes in chronic inflammatory airway diseases, such as asthma and chronic obstructive pulmonary disease (COPD), has garnered significant attention in recent years. This review aims to provide an overview of the current understanding of IL-18 biology, the associated signaling pathways, and the involvement of inflammasome complexes in airway diseases. We explore the multifaceted role of IL-18 in asthma pathophysiology, including its interactions with other cytokines and contributions to both T2 and non-T2 inflammation. Importantly, emerging evidence highlights IL-18 as a critical player in severe asthma, contributing to chronic airway inflammation, airway hyperresponsiveness (AHR), and mucus impaction. Furthermore, we discuss the emerging evidence of IL-18\u2019s involvement in autoimmunity and highlight potential therapeutic targets within the IL-18 and inflammasome pathways in severe asthma patients with evidence of infections and airway autoimmune responses. By synthesizing recent advancements and ongoing research, this review underscores the importance of IL-18 as a potential novel therapeutic target in the treatment of severe asthma and other related conditions.<\/jats:p>","DOI":"10.3389\/fmed.2024.1486780","type":"journal-article","created":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T16:37:43Z","timestamp":1730479063000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["IL-18 biology in severe asthma"],"prefix":"10.3389","volume":"11","author":[{"given":"Sarita","family":"Thawanaphong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aswathi","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Volfson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parameswaran","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manali","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,11,1]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1111\/j.1365-2222.2011.03929.x","article-title":"Severe asthma: from characteristics to phenotypes to endotypes","volume":"42","author":"Wenzel","year":"2012","journal-title":"Clin Exp Allergy"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/nm.2678","article-title":"Asthma phenotypes: the evolution from clinical to molecular approaches","volume":"18","author":"Wenzel","year":"2012","journal-title":"Nat Med"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/j.jaci.2014.08.042","article-title":"The prevalence of severe refractory asthma","volume":"135","author":"Hekking","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"861","DOI":"10.2165\/00002018-200730100-00005","article-title":"Corticosteroid-induced adverse events in adults: frequency, screening and prevention","volume":"30","author":"Fardet","year":"2007","journal-title":"Drug Saf"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1111\/j.1365-2222.2008.02971.x","article-title":"Pathogenesis of asthma","volume":"38","author":"Holgate","year":"2008","journal-title":"Clin Exp Allergy"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1056\/NEJMra2032506","article-title":"Biologic therapies for severe asthma","volume":"386","author":"Brusselle","year":"2022","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3389\/fmed.2017.00158","article-title":"Asthma endotypes and an overview of targeted therapy for asthma","volume":"4","author":"Svenningsen","year":"2017","journal-title":"Front Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jaci.2013.05.007","article-title":"What is an \u201ceosinophilic phenotype\u201d of asthma?","volume":"132","author":"Nair","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.jaci.2024.03.023","article-title":"Utility of eosinophil peroxidase as a biomarker of eosinophilic inflammation in asthma","volume":"154","author":"Tang","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"307","DOI":"10.18176\/jiaci.0628","article-title":"Exacerbations of severe asthma while on anti-IL-5 biologics","volume":"30","author":"Bhalla","year":"2020","journal-title":"J Investig Allergol Clin Immunol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1164\/rccm.201810-1944CI","article-title":"Role of biologics in asthma","volume":"199","author":"McGregor","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"2000117","DOI":"10.1183\/13993003.00117-2020","article-title":"Suboptimal treatment response to anti-IL-5 monoclonal antibodies in severe eosinophilic asthmatics with airway autoimmune phenomena","volume":"56","author":"Mukherjee","year":"2020","journal-title":"Eur Respir J"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1164\/rccm.202308-1413LE","article-title":"Benralizumab normalizes sputum eosinophilia in severe asthma uncontrolled by anti-IL-5 antibodies: a single-blind, placebo-controlled clinical trial","volume":"208","author":"Mukherjee","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"2244","DOI":"10.1111\/all.16011","article-title":"Sputum cytokines associated with raised FeNO after anti-IL5 biologic therapy in severe asthma","volume":"79","author":"Hekking","year":"2024","journal-title":"Allergy"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1080\/02770903.2020.1766061","article-title":"High serum free IL-18 is associated with decreased omalizumab efficacy: findings from a 2-year omalizumab treatment study","volume":"58","author":"Morimoto","year":"2021","journal-title":"J Asthma"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"763","DOI":"10.3389\/fimmu.2018.00763","article-title":"Unique action of interleukin-18 on T cells and other immune cells","volume":"9","author":"Nakanishi","year":"2018","journal-title":"Front Immunol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.cell.2010.01.040","article-title":"The inflammasomes","volume":"140","author":"Schroder","year":"2010","journal-title":"Cell"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/378088a0","article-title":"Cloning of a new cytokine that induces IFN-gamma production by T cells","volume":"378","author":"Okamura","year":"1995","journal-title":"Nature"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1146\/annurev.immunol.19.1.423","article-title":"Interleukin-18 regulates both Th1 and Th2 responses","volume":"19","author":"Nakanishi","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3389\/fimmu.2013.00289","article-title":"Interleukin-18 and IL-18 binding protein","volume":"4","author":"Dinarello","year":"2013","journal-title":"Front Immunol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"104508","DOI":"10.1016\/j.isci.2022.104508","article-title":"Structural basis of the IL-1 receptor TIR domain-mediated IL-1 signaling","volume":"25","author":"Zhou","year":"2022","journal-title":"iScience"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"5340","DOI":"10.1038\/ncomms6340","article-title":"The structural basis for receptor recognition of human interleukin-18","volume":"5","author":"Tsutsumi","year":"2014","journal-title":"Nat Commun"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1111\/imr.12616","article-title":"Interleukin-18: biological properties and role in disease pathogenesis","volume":"281","author":"Kaplanski","year":"2018","journal-title":"Immunol Rev"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"F11","DOI":"10.1084\/jem.194.3.F11","article-title":"Interleukin 18: tipping the balance towards a T helper cell 1 response","volume":"194","author":"Swain","year":"2001","journal-title":"J Exp Med"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1034\/j.1399-3003.1999.14c12.x","article-title":"Airway epithelium expresses interleukin-18","volume":"14","author":"Cameron","year":"1999","journal-title":"Eur Respir J"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"5508","DOI":"10.4049\/jimmunol.1202121","article-title":"Cutting edge: FAS (CD95) mediates noncanonical IL-1\u03b2 and IL-18 maturation via caspase-8 in an RIP3-independent manner","volume":"189","author":"Bossaller","year":"2012","journal-title":"J Immunol"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"649","DOI":"10.3390\/ijms20030649","article-title":"Interleukin-18 in health and disease","volume":"20","author":"Yasuda","year":"2019","journal-title":"Int J Mol Sci"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/s41419-022-04907-5","article-title":"Mitochondrial reactive oxygen is critical for IL-12\/IL-18-induced IFN-\u03b3 production by CD4(+) T cells and is regulated by Fas\/FasL signaling","volume":"13","author":"Rackov","year":"2022","journal-title":"Cell Death Dis"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"696605","DOI":"10.3389\/fimmu.2021.696605","article-title":"Current understanding of IL-37 in human health and disease","volume":"12","author":"Su","year":"2021","journal-title":"Front Immunol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"11125","DOI":"10.3390\/ijms241311125","article-title":"IL-18 in autoinflammatory diseases: focus on adult onset still disease and macrophages activation syndrome","volume":"24","author":"Baggio","year":"2023","journal-title":"Int J Mol Sci"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1016\/S0140-6736(00)04904-7","article-title":"An overview of the immune system","volume":"357","author":"Parkin","year":"2001","journal-title":"Lancet"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1159\/000477172","article-title":"Combined stimulation with interleukin-18 and interleukin-12 potently induces interleukin-8 production by natural killer cells","volume":"9","author":"Poznanski","year":"2017","journal-title":"J Innate Immun"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"7922","DOI":"10.1128\/JVI.00199-15","article-title":"Cytokine-mediated activation of NK cells during viral infection","volume":"89","author":"Freeman","year":"2015","journal-title":"J Virol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1073\/pnas.0813192106","article-title":"Cytokine-induced memory-like natural killer cells","volume":"106","author":"Cooper","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1084\/jem.187.12.2103","article-title":"Murine macrophages secrete interferon gamma upon combined stimulation with interleukin (IL)-12 and IL-18: a novel pathway of autocrine macrophage activation","volume":"187","author":"Munder","year":"1998","journal-title":"J Exp Med"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"e30280","DOI":"10.1371\/journal.pone.0030280","article-title":"Alternaria-induced release of IL-18 from damaged airway epithelial cells: an NF-\u03baB dependent mechanism of Th2 differentiation?","volume":"7","author":"Murai","year":"2012","journal-title":"PLoS One"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.bbrc.2015.05.076","article-title":"Alternaria extract activates autophagy that induces IL-18 release from airway epithelial cells","volume":"464","author":"Murai","year":"2015","journal-title":"Biochem Biophys Res Commun"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1164\/ajrccm.155.4.9105079","article-title":"Alternaria as a major allergen for asthma in children raised in a desert environment","volume":"155","author":"Halonen","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"13962","DOI":"10.1073\/pnas.96.24.13962","article-title":"IL-18, although antiallergic when administered with IL-12, stimulates IL-4 and histamine release by basophils","volume":"96","author":"Yoshimoto","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"3400","DOI":"10.4049\/jimmunol.161.7.3400","article-title":"IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production","volume":"161","author":"Yoshimoto","year":"1998","journal-title":"J Immunol"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1146\/annurev.immunol.14.1.207","article-title":"Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo","volume":"14","author":"K\u00e4gi","year":"1996","journal-title":"Annu Rev Immunol"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.4049\/jimmunol.162.6.3202","article-title":"Development of CD8+ effector T cells is differentially regulated by IL-18 and IL-12","volume":"162","author":"Okamoto","year":"1999","journal-title":"J Immunol"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/77811","article-title":"IL-18 induction of IgE: dependence on CD4+ T cells, IL-4 and STAT6","volume":"1","author":"Yoshimoto","year":"2000","journal-title":"Nat Immunol"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1084\/jem.20021701","article-title":"Nonredundant roles for CD1d-restricted natural killer T cells and conventional CD4+ T cells in the induction of immunoglobulin E antibodies in response to interleukin 18 treatment of mice","volume":"197","author":"Yoshimoto","year":"2003","journal-title":"J Exp Med"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1093\/intimm\/dxr087","article-title":"Requirement of GATA-binding protein 3 for II13 gene expression in IL-18-stimulated Th1 cells","volume":"23","author":"Nakahira","year":"2011","journal-title":"Int Immunol"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/j.1600-065X.2008.00734.x","article-title":"Function of nod-like receptors in microbial recognition and host defense","volume":"227","author":"Franchi","year":"2009","journal-title":"Immunol Rev"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"899","DOI":"10.3390\/ijms21030899","article-title":"NOD-like receptors in the eye: uncovering its role in diabetic retinopathy","volume":"21","author":"Lim","year":"2020","journal-title":"Int J Mol Sci"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1016\/j.cell.2023.04.025","article-title":"A 360\u00b0 view of the inflammasome: mechanisms of activation, cell death, and diseases","volume":"186","author":"Barnett","year":"2023","journal-title":"Cell"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41392-021-00507-5","article-title":"Pyroptosis: mechanisms and diseases","volume":"6","author":"Yu","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"ref50","doi-asserted-by":"publisher","first-page":"2301232","DOI":"10.1183\/13993003.01232-2023","article-title":"Gasdermin B, an asthma-susceptibility gene, promotes MAVS-TBK1 signalling and airway inflammation","volume":"63","author":"Liu","year":"2024","journal-title":"Eur Respir J"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"487","DOI":"10.5114\/ada.2022.118077","article-title":"Inflammasome signalling pathway in the regulation of inflammation \u2013 its involvement in the development and exacerbation of asthma and chronic obstructive pulmonary disease","volume":"40","author":"Panek","year":"2023","journal-title":"Postepy Dermatol Alergol"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/s41590-021-00886-5","article-title":"NLRP3 inflammasome in cancer and metabolic diseases","volume":"22","author":"Sharma","year":"2021","journal-title":"Nat Immunol"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"1007705","DOI":"10.3389\/fimmu.2022.1007705","article-title":"NLRP3 inflammasome and NLRP3-related autoinflammatory diseases: from cryopyrin function to targeted therapies","volume":"13","author":"Moltrasio","year":"2022","journal-title":"Front Immunol"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13223-023-00837-9","article-title":"Autoinflammatory gene mutations associated with eosinophilia and asthma","volume":"19","author":"Alotaibi","year":"2023","journal-title":"Allergy Asthma Clin Immunol"},{"key":"ref55","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.bbi.2020.10.010","article-title":"Impaired autophagy in microglia aggravates dopaminergic neurodegeneration by regulating NLRP3 inflammasome activation in experimental models of Parkinson's disease","volume":"91","author":"Qin","year":"2021","journal-title":"Brain Behav Immun"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.trsl.2022.08.006","article-title":"NLRP3 inflammasome in neurodegenerative disease","volume":"252","author":"Anderson","year":"2023","journal-title":"Transl Res"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.3389\/fimmu.2020.01580","article-title":"Severe COVID-19: NLRP3 inflammasome dysregulated","volume":"11","author":"van den Berg","year":"2020","journal-title":"Front Immunol"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"e0214622","DOI":"10.1371\/journal.pone.0214622","article-title":"NLRP3 inflammasome activity is upregulated in an in-vitro model of COPD exacerbation","volume":"14","author":"Nachmias","year":"2019","journal-title":"PLoS One"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1164\/rccm.201609-1830OC","article-title":"Role for NLRP3 inflammasome-mediated, IL-1beta-dependent responses in severe, steroid-resistant asthma","volume":"196","author":"Kim","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1038\/s41467-023-37470-4","article-title":"Rhinovirus-induced epithelial RIG-I inflammasome suppresses antiviral immunity and promotes inflammation in asthma and COVID-19","volume":"14","author":"Radzikowska","year":"2023","journal-title":"Nat Commun"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.3390\/jcm8101615","article-title":"Targeting NLRP3 inflammasome activation in severe asthma","volume":"8","author":"Theofani","year":"2019","journal-title":"J Clin Med"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"88","DOI":"10.3390\/v14010088","article-title":"Influenza a virus infection activates NLRP3 inflammasome through trans-Golgi network dispersion","volume":"14","author":"Pandey","year":"2022","journal-title":"Viruses"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.virol.2022.01.003","article-title":"SARS-CoV-2 viroporin encoded by ORF3a triggers the NLRP3 inflammatory pathway","volume":"568","author":"Xu","year":"2022","journal-title":"Virology"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1007\/s12275-021-0638-2","article-title":"Mst1\/2-ALK promotes NLRP3 inflammasome activation and cell apoptosis during Listeria monocytogenes infection","volume":"59","author":"Gao","year":"2021","journal-title":"J Microbiol"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"845129","DOI":"10.3389\/fmed.2022.845129","article-title":"NLRP3 Inflammasome-mediated pyroptosis pathway contributes to the pathogenesis of Candida albicans keratitis","volume":"9","author":"Lian","year":"2022","journal-title":"Front Med"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1080\/02713683.2019.1584321","article-title":"Pannexin 1 channels contribute to IL-1\u03b2 expression via NLRP3\/Caspase-1 inflammasome in Aspergillus Fumigatus keratitis","volume":"44","author":"Yang","year":"2019","journal-title":"Curr Eye Res"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/s41586-020-2996-z","article-title":"Galactosaminogalactan activates the inflammasome to provide host protection","volume":"588","author":"Briard","year":"2020","journal-title":"Nature"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"550","DOI":"10.4049\/jimmunol.1800107","article-title":"Charcot-Leyden crystals activate the NLRP3 inflammasome and cause IL-1\u03b2 inflammation in human macrophages","volume":"202","author":"Rodr\u00edguez-Alc\u00e1zar","year":"2019","journal-title":"J Immunol"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11481-024-10101-5","article-title":"New insights on NLRP3 inflammasome: mechanisms of activation, inhibition, and epigenetic regulation","volume":"19","author":"Kodi","year":"2024","journal-title":"J Neuroimmune Pharmacol"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.4049\/jimmunol.2000373","article-title":"Function and regulation of noncanonical Caspase-4\/5\/11 inflammasome","volume":"204","author":"Matikainen","year":"2020","journal-title":"J Immunol"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/s41590-019-0368-3","article-title":"Innate immunity to intracellular LPS","volume":"20","author":"Rathinam","year":"2019","journal-title":"Nat Immunol"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S1097-2765(02)00599-3","article-title":"The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta","volume":"10","author":"Martinon","year":"2002","journal-title":"Mol Cell"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"eaay2002","DOI":"10.1126\/science.aay2002","article-title":"Enteroviral 3C protease activates the human NLRP1 inflammasome in airway epithelia","volume":"370","author":"Robinson","year":"2020","journal-title":"Science"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1016\/j.molcel.2022.04.033","article-title":"Human NLRP1 is a sensor of pathogenic coronavirus 3CL proteases in lung epithelial cells","volume":"82","author":"Plan\u00e8s","year":"2022","journal-title":"Mol Cell"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1038\/s42003-023-05684-3","article-title":"NLRP1-A CINDERELLA STORY: a perspective of recent advances in NLRP1 and the questions they raise","volume":"6","author":"Barry","year":"2023","journal-title":"Commun Biol"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"eabd0811","DOI":"10.1126\/science.abd0811","article-title":"Human NLRP1 is a sensor for double-stranded RNA","volume":"371","author":"Bauernfried","year":"2021","journal-title":"Science"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"e42","DOI":"10.4110\/in.2021.21.e42","article-title":"NLRC4 inflammasome-mediated regulation of eosinophilic functions","volume":"21","author":"Akkaya","year":"2021","journal-title":"Immune Netw"},{"key":"ref78","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.4049\/jimmunol.2200508","article-title":"PANoptosis: a unique innate immune inflammatory cell death modality","volume":"209","author":"Pandian","year":"2022","journal-title":"J Immunol"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12950-021-00286-4","article-title":"AIM2 nuclear exit and inflammasome activation in chronic obstructive pulmonary disease and response to cigarette smoke","volume":"18","author":"Tran","year":"2021","journal-title":"J Inflamm"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"11","DOI":"10.7554\/eLife.72103","article-title":"The DNA sensors AIM2 and IFI16 are SLE autoantigens that bind neutrophil extracellular traps","volume":"11","author":"Antiochos","year":"2022","journal-title":"eLife"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"2200442","DOI":"10.1183\/13993003.00442-2022","article-title":"Airway autoantibodies are determinants of asthma severity","volume":"60","author":"Salter","year":"2022","journal-title":"Eur Respir J"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"2102446","DOI":"10.1183\/13993003.02446-2021","article-title":"Impact of former smoking exposure on airway eosinophilic activation and autoimmunity in patients with severe asthma","volume":"60","author":"Klein","year":"2022","journal-title":"Eur Respir J"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1164\/rccm.202206-1183OC","article-title":"Autoantibody-mediated macrophage dysfunction in patients with severe asthma with airway infections","volume":"207","author":"Son","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"ref84","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1067\/mai.2001.112275","article-title":"IL-18 might reflect disease activity in mild and moderate asthma exacerbation","volume":"107","author":"Tanaka","year":"2001","journal-title":"J Allergy Clin Immunol"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"513","DOI":"10.2332\/allergolint.13-LE-0548","article-title":"Increased serum levels of soluble IL-18 receptor complex in patients with allergic asthma","volume":"62","author":"Imaoka","year":"2013","journal-title":"Allergol Int"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.anai.2013.09.004","article-title":"Interleukin-18 expression, CD8(+) T cells, and eosinophils in lungs of nonsmokers with fatal asthma","volume":"112","author":"Oda","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1183\/09031936.00105013","article-title":"Elevated expression of the NLRP3 inflammasome in neutrophilic asthma","volume":"43","author":"Simpson","year":"2014","journal-title":"Eur Respir J"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1111\/all.15221","article-title":"TFEB signaling attenuates NLRP3-driven inflammatory responses in severe asthma","volume":"77","author":"Theofani","year":"2022","journal-title":"Allergy"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.cytogfr.2019.05.003","article-title":"Synergy of interleukin (IL)-5 and IL-18 in eosinophil mediated pathogenesis of allergic diseases","volume":"47","author":"Kandikattu","year":"2019","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1172\/JCI85664","article-title":"Lung-resident eosinophils represent a distinct regulatory eosinophil subset","volume":"126","author":"Mesnil","year":"2016","journal-title":"J Clin Invest"},{"key":"ref91","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.jaci.2018.02.011","article-title":"A critical role for IL-18 in transformation and maturation of naive eosinophils to pathogenic eosinophils","volume":"142","author":"Venkateshaiah","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1164\/ajrccm.160.3.9805026","article-title":"Interleukin-18 enhances antigen-induced eosinophil recruitment into the mouse airways","volume":"160","author":"Kumano","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1111\/all.15180","article-title":"Role of IL-18-transformed CD274-expressing eosinophils in promoting airway obstruction in experimental asthma","volume":"77","author":"Mishra","year":"2022","journal-title":"Allergy"},{"key":"ref94","article-title":"Sputum c-kit-positive ILC2 in severe asthma express IL-17A: evidence of ILC2 to ILC3 plasticity","author":"Ju","year":"2024","journal-title":"Sci Transl Med"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.jaip.2016.11.030","article-title":"Airway hyperresponsiveness in asthma: measurement and clinical relevance","volume":"5","author":"Nair","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref96","doi-asserted-by":"publisher","first-page":"411s","DOI":"10.1378\/chest.123.3_suppl.411S","article-title":"Airway hyperresponsiveness","volume":"123","author":"O'Byrne","year":"2003","journal-title":"Chest"},{"key":"ref97","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1084\/jem.20031368","article-title":"Interleukin 18 acts on memory T helper cells type 1 to induce airway inflammation and hyperresponsiveness in a naive host mouse","volume":"199","author":"Sugimoto","year":"2004","journal-title":"J Exp Med"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"14765","DOI":"10.1073\/pnas.0706378104","article-title":"T helper 1 cells stimulated with ovalbumin and IL-18 induce airway hyperresponsiveness and lung fibrosis by IFN-gamma and IL-13 production","volume":"104","author":"Hayashi","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"e54623","DOI":"10.1371\/journal.pone.0054623","article-title":"IL-18 induces airway hyperresponsiveness and pulmonary inflammation via CD4+ T cell and IL-13","volume":"8","author":"Sawada","year":"2013","journal-title":"PLoS One"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1164\/rccm.200807-1126OC","article-title":"Severe exacerbations and decline in lung function in asthma","volume":"179","author":"O'Byrne","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1378\/chest.126.6.1875","article-title":"A single measure of FEV1 is associated with risk of asthma attacks in long-term follow-up","volume":"126","author":"Kitch","year":"2004","journal-title":"Chest"},{"key":"ref102","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2020\/4652898","article-title":"Relationship of serum levels of IL-17, IL-18, TNF-\u03b1, and lung function parameters in patients with COPD, asthma-COPD overlap, and bronchial asthma","volume":"2020","author":"Kubysheva","year":"2020","journal-title":"Mediat Inflamm"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"e149945","DOI":"10.1172\/jci.insight.149945","article-title":"Machine learning implicates the IL-18 signaling axis in severe asthma. JCI","volume":"6","author":"Camiolo","year":"2021","journal-title":"Insight"},{"key":"ref104","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.coph.2004.01.011","article-title":"Airway mucus hypersecretion in asthma: an undervalued pathology?","volume":"4","author":"Rogers","year":"2004","journal-title":"Curr Opin Pharmacol"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/01.mcp.0000198064.27586.37","article-title":"Mucus and MUC in asthma","volume":"12","author":"Morcillo","year":"2006","journal-title":"Curr Opin Pulm Med"},{"key":"ref106","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1164\/rccm.201108-1545OC","article-title":"IL-18 induces emphysema and airway and vascular remodeling via IFN-\u03b3, IL-17A, and IL-13","volume":"185","author":"Kang","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"ref107","doi-asserted-by":"publisher","first-page":"428","DOI":"10.4168\/aair.2018.10.5.428","article-title":"Autoimmune responses in severe asthma","volume":"10","author":"Mukherjee","year":"2018","journal-title":"Allergy Asthma Immunol Res"},{"key":"ref108","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1164\/rccm.201804-0809OC","article-title":"Sputum antineutrophil cytoplasmic antibodies in serum antineutrophil cytoplasmic antibody-negative eosinophilic granulomatosis with polyangiitis","volume":"199","author":"Mukherjee","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.jaci.2017.06.033","article-title":"Sputum autoantibodies in patients with severe eosinophilic asthma","volume":"141","author":"Mukherjee","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.3389\/fimmu.2018.02763","article-title":"Eosinophil extracellular traps and inflammatory pathologies-untangling the web!","volume":"9","author":"Mukherjee","year":"2018","journal-title":"Front Immunol"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1002\/art.41727","article-title":"Eosinophil ETosis-mediated release of Galectin-10 in eosinophilic granulomatosis with polyangiitis","volume":"73","author":"Fukuchi","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1182\/blood-2018-04-842260","article-title":"Charcot-Leyden crystal formation is closely associated with eosinophil extracellular trap cell death","volume":"132","author":"Ueki","year":"2018","journal-title":"Blood"},{"key":"ref113","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.coi.2021.03.013","article-title":"Charcot-Leyden crystals and other protein crystals driving type 2 immunity and allergy","volume":"72","author":"Aegerter","year":"2021","journal-title":"Curr Opin Immunol"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1164\/rccm.201707-1323OC","article-title":"Weight-adjusted intravenous reslizumab in severe asthma with inadequate response to fixed-dose subcutaneous mepolizumab","volume":"197","author":"Mukherjee","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"ref115","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1365-2249.2008.03772.x","article-title":"Interleukin-18-deficient mice exhibit diminished chronic inflammation and airway remodelling in ovalbumin-induced asthma model","volume":"154","author":"Yamagata","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"e0247972","DOI":"10.1371\/journal.pone.0247972","article-title":"A pilot study evaluating GSK1070806 inhibition of interleukin-18 in renal transplant delayed graft function","volume":"16","author":"Wlodek","year":"2021","journal-title":"PLoS One"},{"key":"ref117","doi-asserted-by":"publisher","first-page":"e0150018","DOI":"10.1371\/journal.pone.0150018","article-title":"A study to investigate the efficacy and safety of an anti-interleukin-18 monoclonal antibody in the treatment of type 2 diabetes mellitus","volume":"11","author":"McKie","year":"2016","journal-title":"PLoS One"},{"key":"ref118","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/jcmm.13323","article-title":"Role of IL-18 in atopic asthma is determined by balance of IL-18\/IL-18BP\/IL-18R","volume":"22","author":"Zhang","year":"2018","journal-title":"J Cell Mol Med"},{"key":"ref119","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1186\/s12931-017-0675-x","article-title":"The potential of interleukin-37 as an effective therapeutic agent in asthma","volume":"18","author":"Zhang","year":"2017","journal-title":"Respir Res"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"156413","DOI":"10.1016\/j.cyto.2023.156413","article-title":"Albumin-binding recombinant human IL-18BP ameliorates macrophage activation syndrome and atopic dermatitis via direct IL-18 inactivation","volume":"172","author":"Jang","year":"2023","journal-title":"Cytokine"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1136\/annrheumdis-2017-212608","article-title":"Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset still\u2019s disease","volume":"77","author":"Gabay","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"ref122","doi-asserted-by":"publisher","first-page":"e1471","DOI":"10.1002\/ctm2.1471","article-title":"A randomized, double-blind phase 1b study evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of the NLRP3 inhibitor selnoflast in patients with moderate to severe active ulcerative colitis","volume":"13","author":"Klughammer","year":"2023","journal-title":"Clin Transl Med"},{"key":"ref123","doi-asserted-by":"publisher","first-page":"175091","DOI":"10.1016\/j.ejphar.2022.175091","article-title":"Therapeutic potential of MCC950, a specific inhibitor of NLRP3 inflammasome","volume":"928","author":"Li","year":"2022","journal-title":"Eur J Pharmacol"},{"key":"ref124","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s00011-021-01475-w","article-title":"FSTL1 aggravates OVA-induced inflammatory responses by activating the NLRP3\/IL-1\u03b2 signaling pathway in mice and macrophages","volume":"70","author":"Wang","year":"2021","journal-title":"Inflamm Res"},{"key":"ref125","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.molimm.2023.06.013","article-title":"Sodium houttuyfonate plays a protective role in the asthmatic airway by alleviating the NLRP3-related pyroptosis and Th1\/Th2 immune imbalance","volume":"160","author":"Li","year":"2023","journal-title":"Mol Immunol"},{"key":"ref126","doi-asserted-by":"publisher","first-page":"108","DOI":"10.5483\/BMBRep.2012.45.2.108","article-title":"Protopine reduces the inflammatory activity of lipopolysaccharide-stimulated murine macrophages","volume":"45","author":"Bae","year":"2012","journal-title":"BMB Rep"},{"key":"ref127","doi-asserted-by":"publisher","first-page":"155410","DOI":"10.1016\/j.phymed.2024.155410","article-title":"Protopine ameliorates OVA-induced asthma through modulatingTLR4\/MyD88\/NF-\u03baB pathway and NLRP3 inflammasome-mediated pyroptosis","volume":"126","author":"Yang","year":"2024","journal-title":"Phytomedicine"},{"key":"ref128","doi-asserted-by":"publisher","first-page":"102003","DOI":"10.1016\/j.pupt.2021.102003","article-title":"Glucagon-like peptide 1 receptor (GLP-1R) agonist relieved asthmatic airway inflammation via suppression of NLRP3 inflammasome activation in obese asthma mice model","volume":"67","author":"Hur","year":"2021","journal-title":"Pulm Pharmacol Ther"},{"key":"ref129","doi-asserted-by":"publisher","first-page":"1187557","DOI":"10.3389\/fmed.2023.1187557","article-title":"miR-223: a key regulator of pulmonary inflammation","volume":"10","author":"Shi","year":"2023","journal-title":"Front Med"},{"key":"ref130","doi-asserted-by":"publisher","first-page":"e3170","DOI":"10.1038\/cddis.2017.549","article-title":"Ly6G+ neutrophil-derived miR-223 inhibits the NLRP3 inflammasome in mitochondrial DAMP-induced acute lung injury","volume":"8","author":"Feng","year":"2017","journal-title":"Cell Death Dis"},{"key":"ref131","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1016\/j.celrep.2018.01.058","article-title":"MicroRNA-223 suppresses the canonical NF-\u03baB pathway in basal keratinocytes to dampen neutrophilic inflammation","volume":"22","author":"Zhou","year":"2018","journal-title":"Cell Rep"},{"key":"ref132","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12931-020-01374-4","article-title":"MiR-223 plays a protecting role in neutrophilic asthmatic mice through the inhibition of NLRP3 inflammasome","volume":"21","author":"Xu","year":"2020","journal-title":"Respir Res"},{"key":"ref133","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1093\/intimm\/dxl021","article-title":"Contribution of IL-18-induced innate T cell activation to airway inflammation with mucus hypersecretion and airway hyperresponsiveness","volume":"18","author":"Ishikawa","year":"2006","journal-title":"Int Immunol"},{"key":"ref134","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/4743176","article-title":"Correlation of IL-18 with tryptase in atopic asthma and induction of mast cell accumulation by IL-18","volume":"2016","author":"Wang","year":"2016","journal-title":"Mediat Inflamm"},{"key":"ref135","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1183\/09031936.00033811","article-title":"Interleukin-18 and interleukin-18 receptor-\u03b1 expression in allergic asthma","volume":"38","author":"Imaoka","year":"2011","journal-title":"Eur Respir J"},{"key":"ref136","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/s41419-024-06777-5","article-title":"Gasdermin D silencing alleviates airway inflammation and remodeling in an ovalbumin-induced asthmatic mouse model","volume":"15","author":"Wu","year":"2024","journal-title":"Cell Death Dis"},{"key":"ref137","doi-asserted-by":"publisher","first-page":"115587","DOI":"10.1016\/j.biopha.2023.115587","article-title":"Disruption of IL-18 signaling via engineered IL-18BP biologics alleviates experimental cholestatic liver disease","volume":"167","author":"Kim","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"ref138","doi-asserted-by":"publisher","first-page":"8618","DOI":"10.1038\/s41598-018-26775-w","article-title":"MCC950, a specific small molecule inhibitor of NLRP3 inflammasome attenuates colonic inflammation in spontaneous colitis mice","volume":"8","author":"Perera","year":"2018","journal-title":"Sci Rep"},{"key":"ref139","doi-asserted-by":"publisher","first-page":"e3000354","DOI":"10.1371\/journal.pbio.3000354","article-title":"MCC950\/CRID3 potently targets the NACHT domain of wild-type NLRP3 but not disease-associated mutants for inflammasome inhibition","volume":"17","author":"Vande Walle","year":"2019","journal-title":"PLoS Biol"},{"key":"ref140","doi-asserted-by":"publisher","first-page":"112133","DOI":"10.1016\/j.biopha.2021.112133","article-title":"MCC950 attenuates doxorubicin-induced myocardial injury in vivo and in vitro by inhibiting NLRP3-mediated pyroptosis","volume":"143","author":"Zhang","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"ref141","doi-asserted-by":"publisher","first-page":"137032","DOI":"10.1016\/j.neulet.2022.137032","article-title":"NLRP3 inflammasome inhibitor MCC950 reduces cerebral ischemia\/reperfusion induced neuronal ferroptosis","volume":"795","author":"Wu","year":"2023","journal-title":"Neurosci Lett"},{"key":"ref142","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2022\/9444227","article-title":"Blockade of NLRP3\/Caspase-1\/IL-1\u03b2 regulated Th17\/Treg immune imbalance and attenuated the neutrophilic airway inflammation in an ovalbumin-induced murine model of asthma","volume":"2022","author":"Chen","year":"2022","journal-title":"J Immunol Res"},{"key":"ref143","doi-asserted-by":"publisher","first-page":"717","DOI":"10.2147\/JAA.S467774","article-title":"NLRP3 inflammasome deficiency alleviates inflammation and oxidative stress by promoting PINK1\/Parkin-mediated mitophagy in allergic rhinitis mice and nasal epithelial cells","volume":"17","author":"Ding","year":"2024","journal-title":"J Asthma Allergy"},{"key":"ref144","doi-asserted-by":"publisher","first-page":"e0280914","DOI":"10.1371\/journal.pone.0280914","article-title":"Ac-YVAD-cmk ameliorated sevoflurane-induced cognitive dysfunction and revised mitophagy impairment","volume":"18","author":"Zheng","year":"2023","journal-title":"PLoS One"},{"key":"ref145","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/6636621","article-title":"Caspase-1-inhibitor AC-YVAD-CMK inhibits pyroptosis and ameliorates acute kidney injury in a model of sepsis","volume":"2021","author":"Yang","year":"2021","journal-title":"Biomed Res Int"},{"key":"ref146","doi-asserted-by":"publisher","first-page":"4839","DOI":"10.2147\/JIR.S321513","article-title":"Neutrophil extracellular traps augmented alveolar macrophage pyroptosis via AIM2 inflammasome activation in LPS-induced ALI\/ARDS","volume":"14","author":"Li","year":"2021","journal-title":"J Inflamm Res"},{"key":"ref147","doi-asserted-by":"publisher","first-page":"175236","DOI":"10.1016\/j.ejphar.2022.175236","article-title":"Sodium houttuyfonate protects against cardiac injury by regulating cardiac energy metabolism in diabetic rats","volume":"932","author":"Yao","year":"2022","journal-title":"Eur J Pharmacol"},{"key":"ref148","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1186\/s12935-021-02105-5","article-title":"Protopine triggers apoptosis via the intrinsic pathway and regulation of ROS\/PI3K\/Akt signalling pathway in liver carcinoma","volume":"21","author":"Nie","year":"2021","journal-title":"Cancer Cell Int"},{"key":"ref149","doi-asserted-by":"publisher","first-page":"1136070","DOI":"10.3389\/fncel.2023.1136070","article-title":"Effects of liraglutide on astrocyte polarization and neuroinflammation in db\/db mice: focus on iron overload and oxidative stress","volume":"17","author":"An","year":"2023","journal-title":"Front Cell Neurosci"},{"key":"ref150","doi-asserted-by":"publisher","first-page":"405","DOI":"10.2147\/COPD.S350133","article-title":"Respiratory effects of treatment with a glucagon-like peptide-1 receptor agonist in patients suffering from obesity and chronic obstructive pulmonary disease","volume":"17","author":"Altintas Dogan","year":"2022","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"ref151","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.ejphar.2016.10.016","article-title":"Liraglutide attenuates lipopolysaccharide-induced acute lung injury in mice","volume":"791","author":"Zhou","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"ref152","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.bioactmat.2023.06.012","article-title":"Dual-engineered cartilage-targeting extracellular vesicles derived from mesenchymal stem cells enhance osteoarthritis treatment via miR-223\/NLRP3\/pyroptosis axis: toward a precision therapy","volume":"30","author":"Liu","year":"2023","journal-title":"Bioact Mater"},{"key":"ref153","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/1756-185X.14089","article-title":"MiR-223-3p and miR-22-3p inhibit monosodium urate-induced gouty inflammation by targeting NLRP3","volume":"24","author":"Wang","year":"2021","journal-title":"Int J Rheum Dis"}],"updated-by":[{"DOI":"10.3389\/fmed.2025.1558229","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T00:00:00Z","timestamp":1737417600000}}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1486780\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T15:49:04Z","timestamp":1737388144000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1486780\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,1]]},"references-count":153,"alternative-id":["10.3389\/fmed.2024.1486780"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1486780","relation":{"corrigendum":[{"id-type":"doi","id":"10.3389\/fmed.2025.1558229","asserted-by":"object"}]},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,1]]},"article-number":"1486780"}}